Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Bladder Cancer

Free Subscription Articles published in Oncogene Retrieve available abstracts of 19 articles: HTML format

Single Articles

April 2008
1. HURST CD , Tomlinson DC, Williams SV, Platt FM, et al
   Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.
   Oncogene. 2008;27:2716-27.
   PubMed     Related articles    Abstract available
   
   
   March 2008
2. KIDOKORO T , Tanikawa C, Furukawa Y, Katagiri T, et al
   CDC20, a potential cancer therapeutic target, is negatively regulated by p53.
   Oncogene. 2008;27:1562-71.
   PubMed     Related articles    Abstract available
   
   
   November 2007
3. JULIEN S , Puig I, Caretti E, Bonaventure J, et al
   Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition.
   Oncogene. 2007;26:7445-56.
   PubMed     Related articles    Abstract available
   
   
   October 2007
4. GLAROS S , Cirrincione GM, Muchardt C, Kleer CG, et al
   The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
   Oncogene. 2007;26:7058-66.
   PubMed     Related articles    Abstract available
   
   
   
5. BUYTAERT E , Matroule JY, Durinck S, Close P, et al
   Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells.
   Oncogene. 2007;.
   PubMed     Related articles    Abstract available
   
   
   September 2007
6. KANEHIRA M , Harada Y, Takata R, Shuin T, et al
   Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis.
   Oncogene. 2007;26:6448-55.
   PubMed     Related articles    Abstract available
   
   
   July 2007
7. MOUSSA O , Riker JM, Klein J, Fraig M, et al
   Inhibition of thromboxane synthase activity modulates bladder cancer cell responses to chemotherapeutic agents.
   Oncogene. 2007;.
   PubMed     Related articles    Abstract available
   
   
   May 2007
8. OXFORD G , Smith SC, Hampton G, Theodorescu D, et al
   Expression profiling of Ral-depleted bladder cancer cells identifies RREB-1 as a novel transcriptional Ral effector.
   Oncogene. 2007;.
   PubMed     Related articles    Abstract available
   
   
   March 2007
9. TOMLINSON DC , Hurst CD, Knowles MA
   Knockdown by shRNA identifies S249C mutant FGFR3 as a potential therapeutic target in bladder cancer.
   Oncogene. 2007;.
   PubMed     Related articles    Abstract available
   
   
   February 2007
10. WU Y , McRoberts K, Berr SS, Frierson HF Jr, et al
    Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia.
    Oncogene. 2007;26:765-73.
    PubMed     Related articles    Abstract available
    
    
    September 2006
11. LEE MG , Huh JS, Chung SK, Lee JH, et al
    Promoter CpG hypermethylation and downregulation of XAF1 expression in human urogenital malignancies: implication for attenuated p53 response to apoptotic stresses.
    Oncogene. 2006;25:5807-22.
    PubMed     Related articles    Abstract available
    
    
    
12. OEGGERLI M , Schraml P, Ruiz C, Bloch M, et al
    E2F3 is the main target gene of the 6p22 amplicon with high specificity for human bladder cancer.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    
    August 2006
13. OLSSON AY , Feber A, Edwards S, Te Poele R, et al
    Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells.
    Oncogene. 2006;.
    PubMed     Related articles    Abstract available
    
    
    April 2006
14. LINDGREN D , Liedberg F, Andersson A, Chebil G, et al
    Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q.
    Oncogene. 2006;25:2685-96.
    PubMed     Related articles    Abstract available
    
    
    
15. WATANABE J , Nishiyama H, Matsui Y, Ito M, et al
    Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines.
    Oncogene. 2006;25:2500-8.
    PubMed     Related articles    Abstract available
    
    
    
16. LOUHELAINEN JP , Hurst CD, Pitt E, Nishiyama H, et al
    DBC1 re-expression alters the expression of multiple components of the plasminogen pathway.
    Oncogene. 2006;25:2409-19.
    PubMed     Related articles    Abstract available
    
    
    March 2006
17. MONGIAT-ARTUS P , Miquel C, Van der Aa M, Buhard O, et al
    Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tract.
    Oncogene. 2006;25:2113-8.
    PubMed     Related articles    Abstract available
    
    
    
18. HEIN DW
    N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk.
    Oncogene. 2006;25:1649-58.
    PubMed     Related articles    Abstract available
    
    
    February 2006
19. BORZACCHIELLO G , Russo V, Gentile F, Roperto F, et al
    Bovine papillomavirus E5 oncoprotein binds to the activated form of the platelet-derived growth factor beta receptor in naturally occurring bovine urinary bladder tumours.
    Oncogene. 2006;25:1251-60.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: